title: Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus.
abstract: Twenty-four randomly selected clinical and environmental Vibrio vulnificus isolates were tested for virulence in iron-overloaded mice (250 mg of iron dextran per kg of body weight). The log10 50% lethal doses of 17 isolates were lower by greater than or equal to 3.5 log10 units in iron-overloaded mice than in control mice. These isolates were classified as virulent. The 50% lethal doses of these virulent isolates were also lower in mice that were immunosuppressed by treatment with cyclophosphamide (150 mg/kg). Four of the seven isolates initially classified as avirulent were virulent in mice that were simultaneously iron overloaded and immunosuppressed. These isolates were classified as moderately virulent. The remaining three isolates were avirulent under all conditions. The incidence of virulent strains among clinical and environmental isolates did not differ. The virulent isolates produced high titers of hemolysin, were resistant to inactivation by serum complement, produced phenolate siderophore, and utilized transferrin-bound iron. The moderately virulent isolates differed from the virulent isolates only in their increased sensitivity to inactivation by serum complement. The avirulent isolates differed from those of the other two classes in their inability to either produce significant amounts of phenolate siderophore or utilize transferrin-bound iron. A modified agar plate diffusion method for transferrin-bound iron utilization was developed to differentiate the two classes of virulent isolates from the avirulent isolates in vitro.
authors.affiliation: Division of Microbiology, U.S. Food and Drug Administration, Washington, D.C. 20204.
authors.forename: G N
authors.initials: GN
authors.lastname: Stelma
authors.forename: A L
authors.initials: AL
authors.lastname: Reyes
authors.forename: J T
authors.initials: JT
authors.lastname: Peeler
authors.forename: C H
authors.initials: CH
authors.lastname: Johnson
authors.forename: P L
authors.initials: PL
authors.lastname: Spaulding
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004783:Environmental Microbiology; D005260:Female; D006460:Hemolysin Proteins / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy; D007501:Iron / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D014733:Vibrio / Q000145:classification / Q000302:isolation & purification / Q000472:pathogenicity*; D014735:Vibrio Infections / Q000276:immunology / Q000378:metabolism / Q000382:microbiology*; D014774:Virulence
chemical_list: D006460:Hemolysin Proteins; D007501:Iron